Inventor · disambiguated record
Li Zhu
Also filed as: ZHU LI · Zhu li chao
18 granted patents·7 pending applications·52 citations·filing 2011–2025
89Inventor score
Files withCENTAURUS BIOPHARMA CO LTD5PRIMEGENE BEIJING CO LTD4CARNEGIE INST OF WASHINGTON3CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD3BASF SE2
Top patents by PatentIndex Score
25 records- 0190US9926299B2Inhibitors of bruton's tyrosine kinaseCENTAURUS BIOPHARMA CO LTD·Filed 2013·Granted Mar 27, 2018·33 cites·9 claims
- 0285US9309211B2Arylalkene derivatives and use thereof as selective estrogen receptor modulatorsCENTAURUS BIOPHARMA CO LTD·Filed 2012·Granted Apr 12, 2016·11 cites·6 claims
- 0383US10561657B2Pyrrolopyrimidine compoundCENTAURUS BIOPHARMA CO LTD·Filed 2015·Granted Feb 18, 2020·3 cites·19 claims
- 0481US10112922B2Inhibitor of bruton's tyrosine kinaseCENTAURUS BIOPHARMA CO LTD·Filed 2015·Granted Oct 30, 2018·4 cites·8 claims
- 0579US12131665B2Preparation method and application of bionic large intestineUNIV JIANGNAN·Filed 2023·Granted Oct 29, 2024·0 cites·1 claims
- 0677US12129181B2Carbon-based clathrate compoundsCARNEGIE INST OF WASHINGTON·Filed 2022·Granted Oct 29, 2024·0 cites·7 claims
- 0772US11691890B2Carbon-based clathrate compoundsCARNEGIE INST OF WASHINGTON·Filed 2020·Granted Jul 4, 2023·0 cites·12 claims
- 0868US2025066216A1Carbon-based clathrate compoundsCARNEGIE INST OF WASHINGTON·Filed 2024·Application pending·0 cites
- 0962US2025163055A1Polymorph of jak tyrosine kinase inhibitor and preparation method thereforPRIME GENE THERAPEUTICS CO LTD·Filed 2023·Application pending·0 cites
- 1060US11939708B2Weft-knitted spacer fabric and a preparation method thereof, use of the fabric for the preparation of a composite material and a composite material comprising the sameBASF SE·Filed 2019·Granted Mar 26, 2024·1 cites·26 claims
- 1160US11721241B2Bionic digestive tract as well as preparation method and application thereofUNIV JIANGNAN·Filed 2020·Granted Aug 8, 2023·0 cites·1 claims
- 1259US2024376246A1One-pot process for the production of polycarbodiimide cured polymersBASF SE·Filed 2022·Application pending·0 cites
- 1359US2025082692A1Engineered microorganism for treating hyperphenylalaninemia and use thereofCOMMBIO THERAPEUTICS CO LTD·Filed 2023·Application pending·0 cites
- 1454US2025270612A1Fungus synthesizing 24-epi-ergosterol, construction method therefor, and use thereofNINGBO XINBIO BIOLOGICAL SCI & TECH CO LTD·Filed 2025·Application pending·0 cites
- 1552US10617692B2Pyrrolopyrimidine comprising cyclopentyl substituentCENTAURUS BIOPHARMA CO LTD·Filed 2017·Granted Apr 14, 2020·0 cites·14 claims
- 1651US2023303578A1Preparation method for pyrrolopyrimidine compoundPRIMEGENE BEIJING CO LTD·Filed 2021·Application pending·0 cites
- 1746US12404275B2Pyrazolopyrazine derived compounds, pharmaceutical composition and use thereofPRIMEGENE BEIJING CO LTD·Filed 2020·Granted Sep 2, 2025·0 cites·12 claims
- 1845US11150496B2Adjustable optical switch based on PLZST antiferroelectric photonic crystal, and adjusting and control method thereofUNIV HUBEI MINZU·Filed 2021·Granted Oct 19, 2021·0 cites·10 claims
- 1944US11203586B2Iridinesulfonamide compound and use method thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Dec 21, 2021·0 cites·16 claims
- 2043US12304898B2Quinolyl-containing compound and pharmaceutical composition, and use thereofPRIMEGENE BEIJING CO LTD·Filed 2020·Granted May 20, 2025·0 cites·10 claims
- 2142US12129258B2Diaryl macrocyclic compound and pharmaceutical composition, and use thereofPRIMEGENE BEIJING CO LTD·Filed 2019·Granted Oct 29, 2024·0 cites·7 claims
- 2242US11111240B2Sultam compound and application method thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Sep 7, 2021·0 cites·20 claims
- 2339US10829492B2Amino pyrazolopyrimidine compound used as neurotrophic factor tyrosine kinase receptor inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Nov 10, 2020·0 cites·20 claims
- 2433US9540396B26-arylamino pyridone carboxamide as MEK inhibitorsXIAO DENGMING·Filed 2011·Granted Jan 10, 2017·0 cites·10 claims
- 2530US2014018303A13-Amino-2-Hydroxy-4-Phenylbutanoyl-Valyl-Isoleucine, Preparation and Use ThereofRAO MIN·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →